Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07687836

Retrospective Evaluation of the Implementation of a Digital Solution Supporting the Delivery of Pulmonary Rehabilitation Programs in Private Physiotherapy Practice

Pulmonary rehabilitation improves exercise capacity, functional status, symptoms and quality of life in individuals with chronic respiratory diseases. However, access to pulmonary rehabilitation remains limited due to insufficient availability of specialized centers and geographical, organizational, logistical, and financial barriers. Delivering pulmonary rehabilitation in private physiotherapy practices may improve access to care, but implementation can be challenged by limited resources, equipment, and support tools.

A field-based implementation program was conducted from summer 2025 to support physiotherapists in delivering pulmonary rehabilitation in private practice through the provision of a digital support solution (TELEREHAPP) and, where appropriate, associated equipment. During this program, physiotherapists collected data on solution use, patient characteristics, and available clinical follow-up indicators. Satisfaction and perceived usability were assessed among both physiotherapists and patients.

This retrospective study aims to analyze the data already collected during the implementation program to evaluate the feasibility of implementation, use, and acceptability of the TELEREHAPP digital solution in private physiotherapy practice, and to describe changes in available clinical outcomes among participating patients.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age superior to 18 years;
  • Referred for pulmonary rehabilitation in private physiotherapy practice.

Non-inclusion Criteria:

  • Not applicable

Exclusion criteria

  • Not applicable

Treatment and study plan

TELEREHAPP-supported pulmonary rehabilitation

Device

Pulmonary rehabilitation supported by TELEREHAPP consisted of a program delivered in private physiotherapy practice using a digital health application designed to support the implementation, monitoring, and follow-up of rehabilitation and physical activity programs. Depending on the physiotherapist's usual practice and the patient's needs, the program could include endurance exercise training, muscle strengthening, physical activity coaching, self-administered questionnaires, and individualized monitoring by the physiotherapist. The digital solution was used as a support tool for care delivery and follow-up; the content, duration, frequency, and modalities of the program were determined by the treating physiotherapist.

Primary outcomes

  1. Physiotherapist Adoption of the Digital Solution

    Time frame: 6 to 10 months

    Proportion of equipped physiotherapists who used the solution to support at least one patient during the experimentation period.

Secondary outcomes

  1. Physiotherapist Acceptance Rate

    Time frame: Baseline

    Proportion of contacted physiotherapists who agreed to be equipped with the digital solution.

  2. Number of Patients Managed

    Time frame: 6 to 10 months

    Total number of patients managed, number per physiotherapist, and number per physiotherapist per month.

  3. Modules Used

    Time frame: 6 to 10 months

    Types of modules used within the digital solution (endurance training, muscle strengthening, physical activity coaching, self-administered questionnaires).

  4. Number of Sessions Completed

    Time frame: 6 to 10 months

    Number of sessions completed for each module.

  5. Program Duration

    Time frame: 6 to 10 months

    Duration of the proposed programs.

  6. Program Frequency

    Time frame: 6 to 10 months

    Frequency of the proposed programs.

  7. Physiotherapist Satisfaction

    Time frame: 6 to 10 months

    Satisfaction of physiotherapists with the care pathway involving the digital solution, assessed using an adapted Client Satisfaction Questionnaire-8 items. Scores therefore range from 8 to 32, with higher values indicating higher satisfaction.

  8. Patient Satisfaction

    Time frame: 6 to 10 months

    Satisfaction of patients with the care pathway involving the digital solution, assessed using the Client Satisfaction Questionnaire-8 items. Scores therefore range from 8 to 32, with higher values indicating higher satisfaction.

  9. Perceived Usability - Physiotherapists

    Time frame: 6 to 10 months

    Perceived usability of the digital solution by physiotherapists, assessed using the System Usability Scale. Scores therefore range from 0 to 100, with higher values indicating higher satisfaction.

  10. Perceived Usability - Patients

    Time frame: 6 to 10 months

    Perceived usability of the digital solution by patients, assessed using the System Usability Scale. Scores therefore range from 0 to 100, with higher values indicating higher satisfaction.

  11. Exercise Capacity - 6-Minute Walk Distance

    Time frame: 8 to 10 weeks

    Exercise capacity will be assessed using the 6-Minute Walk Test (6MWT) before and after the rehabilitation program. The test measures the distance walked in 6 minutes, expressed in meters, with higher values indicating greater exercise capacity.

  12. Exercise Capacity - 6-Minute Stepper Test (6MST)

    Time frame: 8 to 10 weeks

    Exercise capacity will be assessed using the 6-Minute Stepper Test (6MST) before and after the rehabilitation program. The outcome is the number of steps completed during the test over 6 minutes. Higher values indicate better exercise capacity.

  13. Exercise Capacity - 1-Minute Sit-to-Stand Test (1STS)

    Time frame: 8 to 10 weeks

    Exercise capacity will be assessed using the 1-Minute Sit-to-Stand Test (1STS) before and after the rehabilitation program. The test measures the number of sit-to-stand repetitions completed in 1 minute, with higher values indicating greater exercise capacity.

  14. Health Status

    Time frame: 8 to 10 weeks

    Health status will be assessed using the Chronic obstructive pulmonary disease Assessment Test (CAT) before and after the rehabilitation program and after 1 year of the enrollement date. The score ranges from 0 to 40, with higher values indicating greater impairment of health status. The established minimal clinically important difference for this questionnaire is -2.5 points.

  15. Respiratory Quality of Life

    Time frame: 8 to 10 weeks

    Assessed using the Visual Simplified Respiratory Questionnaire (VSRQ). The score ranges from 0 to 80, with higher values indicating greater quality of life. The established minimal clinically important difference for this questionnaire is 3.4 points.

  16. Psychological Status - Anxiety

    Time frame: 8 to 10 weeks

    Symptoms of anxiety will be assessed using the Hospital Anxiety and Depression questionnaire, anxiety subscore, before and after the rehabilitation program and after 1 year of the enrollement date. The score ranges from 0 (best) to 21 (worst). The pre-specified minimal clinically important difference is set at -1.5 point.

  17. Psychological Status - Depression

    Time frame: 8 to 10 weeks

    Symptoms of anxiety will be assessed using the Hospital Anxiety and Depression questionnaire, anxiety subscore, before and after the rehabilitation program and after 1 year of the enrollement date. The score ranges from 0 (best) to 21 (worst). The pre-specified minimal clinically important difference is set at -1.5 point.

Sponsors and collaborators

Lead sponsor

ADIR Association

Other

Registry information

Acronym: DIGILIB-RR

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Jul 7, 2026
Registry last updated
Jul 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.